Login / Signup

Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study - a prospective single-arm intervention trial.

Anmol DesaiLauren O'NealKia ReinisPatrick ChangCristal BrownMichael StefanowiczAudrey KuangDeepak AgrawalDarlene BhavnaniTim Mercer
Published in: Pilot and feasibility studies (2023)
Registered on ClinicalTrials.gov on July, 14, 2022. Identifier: NCT05460130 .
Keyphrases
  • hepatitis c virus
  • randomized controlled trial
  • study protocol
  • healthcare
  • primary care
  • human immunodeficiency virus
  • clinical trial
  • phase iii
  • quality improvement
  • hiv infected
  • combination therapy
  • phase ii